RISEDRONATE
risedronate sodium 35 mg enteric tablet, 4
RISEDRONATE (13364J)
13364J
Manner of administration:Oral
Restriction
Indication: Corticosteroid-induced osteoporosis
Restriction
Indication: Osteoporosis
Restriction
Indication: Established osteoporosis
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 8 | # of repeats: 5 | DPMQ: $54.64 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Actonel EC | |||||